These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9836290)

  • 21. Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.
    Weissert R; Lobell A; de Graaf KL; Eltayeb SY; Andersson R; Olsson T; Wigzell H
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1689-94. PubMed ID: 10677519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.
    Grogan JL; Kramer A; Nogai A; Dong L; Ohde M; Schneider-Mergener J; Kamradt T
    J Immunol; 1999 Oct; 163(7):3764-70. PubMed ID: 10490973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
    J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
    de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligoclonal IgG in Lewis rats with experimental allergic encephalomyelitis.
    Whittaker KM; Whitacre CC
    Prog Clin Biol Res; 1984; 146():335-40. PubMed ID: 6201905
    [No Abstract]   [Full Text] [Related]  

  • 26. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD24 and myosin light polypeptide 2 are involved in prevention of experimental autoimmune encephalomyelitis by myelin basic protein-pulsed dendritic cells.
    Liu X; Lindberg R; Xiao BG; Steffensen KR; Leppert D; Link H; Huang YM
    J Neuroimmunol; 2006 Mar; 172(1-2):137-44. PubMed ID: 16380169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral testosterone in male rats and the development of experimental autoimmune encephalomyelitis.
    Macció DR; Calfa G; Roth GA
    Neuroimmunomodulation; 2005; 12(4):246-54. PubMed ID: 15990455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC restriction: slip-sliding away.
    Wilson IA; Stanfield RL
    Nat Immunol; 2005 May; 6(5):434-5. PubMed ID: 15843798
    [No Abstract]   [Full Text] [Related]  

  • 31. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
    Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
    J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity of the B cell repertoire to myelin basic protein in rat strains susceptible and resistant to EAE.
    Figueiredo AC; Cohen IR; Mor F
    J Autoimmun; 1999 Feb; 12(1):13-25. PubMed ID: 10028018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus JHM infection of rats as a model for virus induced demyelinating encephalomyelitis.
    Wege H; Watanabe R; ter Meulen V
    Prog Clin Biol Res; 1984; 146():13-22. PubMed ID: 6201885
    [No Abstract]   [Full Text] [Related]  

  • 35. Species-restricted encephalitogenic determinants.
    Alvord EC
    Prog Clin Biol Res; 1984; 146():523-37. PubMed ID: 6201922
    [No Abstract]   [Full Text] [Related]  

  • 36. [Theoretical conformational analysis of a encephalitogenic peptide molecule and a study of the structure-activity relationship in a series of its analogs].
    Golubovich VP; Kirnarskiĭ LI; Galaktionov SG
    Biofizika; 1989; 34(3):368-71. PubMed ID: 2475178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myelin proteins and demyelinating disease (author's transl)].
    Uyemura K; Kitamura K; Yamanaka T
    Tanpakushitsu Kakusan Koso; 1974 Oct; 19(11):1018-32. PubMed ID: 4140549
    [No Abstract]   [Full Text] [Related]  

  • 38. [Basic encephalitogenic proteins: structure, immunologic activity and disintegrative changes].
    Cendrowski W
    Neuropatol Pol; 1974; 12(1):89-95. PubMed ID: 4136302
    [No Abstract]   [Full Text] [Related]  

  • 39. Myelin basic protein speciation.
    Martenson RE
    Prog Clin Biol Res; 1984; 146():511-21. PubMed ID: 6201921
    [No Abstract]   [Full Text] [Related]  

  • 40. Shared T-cell receptor gene usage in experimental allergic neuritis and encephalomyelitis.
    Jung S; Hartung HP; Toyka KV
    Ann Neurol; 1993 Jul; 34(1):113-4. PubMed ID: 8517671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.